Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Annals of Hematology
|
June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation
Stefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Annals of Hematology
|
November 16, 2020
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Annals of Hematology
|
June 23, 2021
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Leukemia
|
August 6, 2025
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings
Johannes Schetelig, Henning Baldauf, Carina Rave, et al.
Bone Marrow Transplantation
|
March 13, 2025
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis
Osama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, et al.
Leukemia
|
March 6, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries
Johannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Leukemia & Lymphoma
|
January 5, 2021
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysis
Jan M Middeke, Raphael Teipel, Christoph Röllig, et al.
Bone Marrow Transplantation
|
August 5, 2023
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT
Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, et al.
JAMA Oncology
|
February 9, 2023
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial
Martin Bornhäuser, Christoph Schliemann, Johannes Schetelig, et al.
Leukemia
|
July 2, 2025
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment
Julian Ronnacker, Leo Ruhnke, Christoph Röllig, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Annals of Hematology
|
June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation
Stefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Annals of Hematology
|
November 16, 2020
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Annals of Hematology
|
June 23, 2021
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Leukemia
|
August 6, 2025
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings
Johannes Schetelig, Henning Baldauf, Carina Rave, et al.
Bone Marrow Transplantation
|
March 13, 2025
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis
Osama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, et al.
Leukemia
|
March 6, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries
Johannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Leukemia & Lymphoma
|
January 5, 2021
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysis
Jan M Middeke, Raphael Teipel, Christoph Röllig, et al.
Bone Marrow Transplantation
|
August 5, 2023
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT
Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, et al.
JAMA Oncology
|
February 9, 2023
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial
Martin Bornhäuser, Christoph Schliemann, Johannes Schetelig, et al.
Leukemia
|
July 2, 2025
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment
Julian Ronnacker, Leo Ruhnke, Christoph Röllig, et al.
Page
of 11